John Martin Corkery (John M Corkery)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Oxide Nanoparticles

Top Venues

Journal of psychopharmacology (Oxford, England)

Pharmaceuticals (Basel, Switzerland)

Pharmacy (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Davide Arillotta, Giuseppe Floresta, G Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. Brain sciences 14 (6) (2024)
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John Martin Corkery, Jacqueline L Stair, Fabrizio Schifano, Amira Guirguis
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy (Basel, Switzerland) 12 (1) (2024)
Davide Arillotta, Giuseppe Floresta, G Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. Brain sciences 14 (6) (2024)
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John Martin Corkery, Jacqueline L Stair, Fabrizio Schifano, Amira Guirguis
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy (Basel, Switzerland) 12 (1) (2024)
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John Martin Corkery, Jacqueline L Stair, Fabrizio Schifano, Amira Guirguis
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy (Basel, Switzerland) 12 (1) (2024)
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L Sensi, Fabrizio Schifano
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain sciences 13 (11) (2023)
Stefania Chiappini, Rachel Vickers Smith, Daniel R Harris, G Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L Sensi, Fabrizio Schifano
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Maria Semeraro, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano, Massimo Di Giannantonio
Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines 10 (2) (2022)
John Martin Corkery, Amira Guirguis, Stefania Chiappini, Giovanni Martinotti, Fabrizio Schifano
Alprazolam-related deaths in Scotland, 2004-2020. Journal of psychopharmacology (Oxford, England) 36 (9) (2022)
Stefania Chiappini, Rachel Vickers Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Daniel R Harris, Fabrizio Schifano
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Stefania Chiappini, Rachel Vickers Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirguis
Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. Journal of psychopharmacology (Oxford, England) 35 (6) (2021)
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Laura Orsolini, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Giovanni Martinotti, Massimo Di Giannantonio, Fabrizio Schifano
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina (Kaunas, Lithuania) 57 (6) (2021)
John Martin Corkery, Wan-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S Copeland, Fabrizio Schifano
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019. Journal of psychopharmacology (Oxford, England) 35 (11) (2021)
Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis. Brain sciences 11 (7) (2021)
Valeria Catalani, Michelle J Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano
The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Elena Deligianni, Omari J Daniel, John Martin Corkery, Fabrizio Schifano, Lisa A Lione
Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances. British journal of clinical pharmacology 86 (3) (2020)
Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirguis
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database. Brain sciences 10 (2) (2020)
John Martin Corkery, Fabrizio Schifano, Giovanni Martinotti
How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances. British journal of clinical pharmacology 86 (3) (2020)
Fabrizio Schifano, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Liam Gilgar, Amira Guirguis, John Martin Corkery, Alessandro Vento
The clinical challenges of synthetic cathinones. British journal of clinical pharmacology 86 (3) (2020)
John Martin Corkery, Peter Streete, Hugh Claridge, Christine Goodair, Duccio Papanti, Laura Orsolini, Fabrizio Schifano, Kanav Sikka, Sophie Körber, Amy Hendricks
Characteristics of deaths associated with kratom use. Journal of psychopharmacology (Oxford, England) 33 (9) (2019)